Pilot Study Evaluating Panitumumab-IRDye800 as an Optical Imaging Agent to Detect Intracranial Lesions During Neurosurgical Procedures
Vanderbilt-Ingram Cancer Center
Vanderbilt-Ingram Cancer Center
Medical College of Wisconsin
Xuanwu Hospital, Beijing
Universitat Autonoma de Barcelona
University of Southern California
Massachusetts General Hospital
West China Hospital
Henry Ford Health System
Massachusetts Eye and Ear Infirmary
Massachusetts Eye and Ear Infirmary
Aalto University
Johns Hopkins University
Massachusetts General Hospital
King's College Hospital NHS Trust
Charles University, Czech Republic
Beijing Tiantan Hospital
Cedars-Sinai Medical Center
Hospices Civils de Lyon
Children's Hospital Medical Center, Cincinnati
Massachusetts Eye and Ear Infirmary
Northwell Health
Haukeland University Hospital
Ohio State University
University of Utah
Centre Hospitalier Universitaire de Besancon
Northern Care Alliance NHS Foundation Trust
University Hospital, Toulouse
Washington University School of Medicine
Karolinska Institutet
Jonsson Comprehensive Cancer Center
Medical University of Vienna
Mayo Clinic
Mayo Clinic
Assistance Publique Hopitaux De Marseille
Henry Ford Health System
Massachusetts Eye and Ear Infirmary
University of California, Irvine
University Hospital Tuebingen
Medical University of Vienna
Cairo University
Vanderbilt University Medical Center
NYU Langone Health
Beijing Tiantan Hospital
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Northwestern University
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Lund University
Lund University
NYU Langone Health
Taipei Medical University Shuang Ho Hospital